Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Sarepta plunges after third patient death tied to gene therapy - report (SeekingAlpha) +++ SAREPTA Aktie -5,32%

BEONE ADR Aktie

 >BEONE ADR Aktienkurs 
260 EUR    +4.0%    (Tradegate)
Ask: 262 EUR / 30 Stück
Bid: 258 EUR / 30 Stück
Tagesumsatz: 15 Stück
Realtime Kurs von 8 bis 22 Uhr!
BEONE ADR Aktie über LYNX handeln
>BEONE ADR Performance
1 Woche: +14,3%
1 Monat: +12,2%
3 Monate: +22,8%
6 Monate: +22,8%
1 Jahr: +77,1%
laufendes Jahr: +44,2%
>BEONE ADR Aktie
Name:  BEONE MEDICINES SP.ADR
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US07725L1026 / A1437N
Symbol/ Ticker:  49BA (Frankfurt) / ONC (NASDAQ)
Kürzel:  FRA:49BA, ETR:49BA, 49BA:GR, NASDAQ:ONC
Index:  -
Webseite:  https://www.beigene.com/
Marktkapitalisierung:  27000 Mio. EUR
Umsatz:  3619.02 Mio. EUR
EBITDA:  -105.64 Mio. EUR
Gewinn je Aktie:  -2.719 EUR
Schulden:  863.05 Mio. EUR
Liquide Mittel:  2181.8 Mio. EUR
Umsatz-/ Gewinnwachstum:  48.6% / -
KGV/ KGV lG:  - / 151.52
KUV/ KBV/ PEG:  6.96 / 8.39 / -
Gewinnm./ Eigenkapitalr.:  -9.4% / -11.44%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 11.494.902 USD.
Suchwörter:  BEONE ADR, BEONE, BEIGENE
Letzte Datenerhebung:  18.07.25
>BEONE ADR Eigentümer
Aktien: 99.37 Mio. St.
f.h. Aktien: 930.47 Mio. St.
Insider Eigner: 17.32%
Instit. Eigner: 40.03%
>BEONE ADR Peer Group

 
17.07.25 - 10:30
Full-day Takeaway: HSI Closes at 24,498, Down 18 pts; HSTI Closes at 5,448, Up 30 pts; BEIGENE Up over 10%; BEIGENE, SINO BIOPHARM, HANSOH PHARMA, JOHNSON ELEC H, KEYMED BIO-B Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 18 pts or 0.1% to 24,498. HSTI rose 30 pts or 0.6% to 5,448. HSCEI fell 8 pts or 0.1% to 8,853. Market turnover reached $236.41 billion.Active Heavyweights:XIAOMI (01810.HK) closed at $56.15, down 2%BABA (09988.HK) closed at $112.5, down 1.1%MEITUAN (03690.HK) closed at $125.5, up 1.1%CCB (00939.HK) closed ......
17.07.25 - 06:15
Midday Takeaway: HSI Closes Midday at 24,534, Up 17 pts; HSTI Closes Midday at 5,434, Up 15 pts; BEIGENE Up over 8%; BEIGENE, HANSOH PHARMA, CHINAHONGQIAO, JOHNSON ELEC H, KEYMED BIO-B Hit New Highs (AAStocks)
 
At midday close, HSI rose 17 pts or 0.1% to 24,534. HSTI rose 15 pts or 0.3% to 5,434. HSCEI gained 4 pts or 0.0% to 8,865.Active Heavyweights:MEITUAN (03690.HK) closed at $126.2, up 1.7%XIAOMI (01810.HK) closed at $56.45, down 1.5%BABA (09988.HK) closed at $113.1, down 0.6%TENCENT (00700.HK) closed at $516, down 0.1%HSI & HSCEI......
16.07.25 - 12:06
BeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6 (Business Wire)
 
SAN CARLOS, Calif.--(BUSINESS WIRE)--$ONC #BeOne--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2025 financial results on Wednesday, August 6, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company's website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company's website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology ...
16.07.25 - 07:00
Research: BOCOMI Ratings, TPs on CN Pharma Stocks (Table) (AAStocks)
 
Stock | Rating | TP (HK$)BEIGENE(06160.HK) | Buy | 208.8INNOVENT BIO(01801.HK) | Buy | 84AKESO(09926.HK) | Buy | 1403SBIO(01530.HK) | Buy | 27SKB BIO-B(06990.HK) | Buy | 400HUTCHMED(00013.HK) | Buy | 44REMEGEN(09995.HK) | Buy | 66GENSCRIPT BIO(01548.HK) | Buy | 28.75EVEREST MED(01952.HK) | Buy | 72.5KEYMED BIO-B(02162.HK) | Buy ......
12.07.25 - 00:01
Insiderhandel: Chief Executive Officer verkauft Aktien von BeiGene im Wert von 7044591 USD (Insiderkauf)
 
Oyler, John - Vorstand - Tag der Transaktion: 2025-07-09...
10.07.25 - 16:57
BeOne gets EU nod for nasopharyngeal cancer therapy (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.06.25 - 05:45
Research: Nomura: BEIGENE Hikes No. of Preclinical Studies to 85 This Yr, Conducting 96 Clinical Trials (AAStocks)
 
BEIGENE (06160.HK) held an R&D day in New York on Thursday (26th), where management emphasized the Company's R&D capabilities in terms of quality, speed and cost, Nomura published a research report saying. The Company has increased the number of preclinical studies from 20 in 2019 to 85 this year, while new molecules......
26.06.25 - 01:01
Insiderhandel: Chief Executive Officer verkauft Aktien von BeiGene im Wert von 830360 USD (Insiderkauf)
 
Oyler, John - Vorstand - Tag der Transaktion: 2025-06-23...
26.06.25 - 01:01
Insiderhandel: Aufsichtsrat verkauft Aktien von BeiGene im Wert von 532868 USD (Insiderkauf)
 
Wang, Xiaodong - Aufsichtsrat - Tag der Transaktion: 2025-06-24...
26.06.25 - 01:01
Insiderhandel: President and COO verkauft Aktien von BeiGene im Wert von 354380 USD (Insiderkauf)
 
Wu, Xiaobin - Vorstand - Tag der Transaktion: 2025-06-23...
26.06.25 - 01:01
Insiderhandel: Global Head of R&D verkauft Aktien von BeiGene im Wert von 267280 USD (Insiderkauf)
 
Wang, Lai - Vorstand - Tag der Transaktion: 2025-06-23...
23.06.25 - 10:15
Full-day Takeaway: HSI Closes at 23,689, Up 158 pts; HSTI Closes at 5,187, Up 53 pts; BEIGENE Up over 6%; CCB, LINK REIT, ABC, BOC HONG KONG, ICBC Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 158 pts or 0.7% to 23,689. HSTI rose 53 pts or 1.0% to 5,187. HSCEI gained 70 pts or 0.8% to 8,597. Market turnover reached $198.59 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $131.4, up 2.2%HKEX (00388.HK) closed at $399, up 1.6%XIAOMI (01810.HK) closed at $54.85, up 1.5%CCB (00939.HK) closed at ......
23.06.25 - 09:45
Research: BOCOMI Ratings, TPs on Pharmas (Table) (AAStocks)
 
Stocks | Ratings | Target Prices AstraZeneca (AZN.US) | Buy | USD93.3 BEIGENE (06160.HK) | Buy | HKD208.8 HANSOH PHARMA (03692.HK) | Buy | HKD33 INNOVENT BIO (01801.HK) | Buy | HKD84 SINO BIOPHARM (01177.HK) | Buy | HKD5.9 SKB BIO-B (06990.HK) | Buy | HKD400 Legend Biotech (LEGN.US) | Buy | USD65 WUXI XDC (02268.HK) | Buy | HKD5......
23.06.25 - 09:00
Research: CMBI Recommends 3 3SBIO/ BEIGENE/ INNOVENT BIO/ GIANT BIOGENE; CN Pharmas to Face ST Pullback Pressure (AAStocks)
 
The MSCI China Health Care Index has already snowballed by 31.7% YTD, outpacing the MSCI China Index by 18.2%, according to a report from CMBI. Due to the market's high expectations for the frequency and scale of overseas transactions, it is expected that the industry may still face some pullback pressure in the short term.C......
19.06.25 - 00:01
Insiderhandel: SVP, General Counsel verkauft Aktien von BeiGene im Wert von 112463 USD (Insiderkauf)
 
Lee, Chan Henry - Vorstand - Tag der Transaktion: 2025-06-16...
19.06.25 - 00:01
Insiderhandel: Global Head of R&D verkauft Aktien von BeiGene im Wert von 118142 USD (Insiderkauf)
 
Wang, Lai - Vorstand - Tag der Transaktion: 2025-06-17...
19.06.25 - 00:01
Insiderhandel: Global Head of R&D verkauft Aktien von BeiGene im Wert von 313558 USD (Insiderkauf)
 
Wang, Lai - Vorstand - Tag der Transaktion: 2025-06-16...
19.06.25 - 00:01
Insiderhandel: President and COO verkauft Aktien von BeiGene im Wert von 158047 USD (Insiderkauf)
 
Wu, Xiaobin - Vorstand - Tag der Transaktion: 2025-06-17...
19.06.25 - 00:01
Insiderhandel: President and COO verkauft Aktien von BeiGene im Wert von 409694 USD (Insiderkauf)
 
Wu, Xiaobin - Vorstand - Tag der Transaktion: 2025-06-16...
19.06.25 - 00:01
Insiderhandel: Chief Executive Officer verkauft Aktien von BeiGene im Wert von 979046 USD (Insiderkauf)
 
Oyler, John - Vorstand - Tag der Transaktion: 2025-06-16...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der König der Flöhe ist in Tiberias. - D. h., das Schlechte mag eine ganz andere Ursache haben als man vermutet. - Sprichwort Arabisch
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!